Influence of Gut Microbiota and its Metabolites on Progression of Metabolic Associated Fatty Liver Disease / 中国医学科学杂志(英文版)
Chinese Medical Sciences Journal
; (4): 286-296, 2023.
Article
em En
| WPRIM
| ID: wpr-1009000
Biblioteca responsável:
WPRO
ABSTRACT
Metabolic associated fatty liver disease (MAFLD) has become a prevalent chronic liver disease worldwide because of lifestyle and dietary changes. Gut microbiota and its metabolites have been shown to play a critical role in the pathogenesis of MAFLD. Understanding of the function of gut microbiota and its metabolites in MAFLD may help to elucidate pathological mechanisms, identify diagnostic markers, and develop drugs or probiotics for the treatment of MAFLD. Here we review the pathogenesis of MAFLD by gut microbiota and its metabolites and discuss the feasibility of treating MAFLD from the perspective of gut microbes.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Fígado Gorduroso
/
Microbioma Gastrointestinal
Limite:
Humans
Idioma:
En
Revista:
Chinese Medical Sciences Journal
Ano de publicação:
2023
Tipo de documento:
Article